These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38943428)

  • 1. Autologous umbilical cord blood infusion for the treatment of autism in young children: A within-subjects open label study on safety (assessed via caregiver report) and efficacy.
    Wong CM; Tan CS; Riard N; Padmini YS; Daniel LM; Prasath A; Tan AM; Tan TC; Sultana R; Lam JCM
    Autism Res; 2024 Aug; 17(8):1721-1734. PubMed ID: 38943428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder.
    Dawson G; Sun JM; Baker J; Carpenter K; Compton S; Deaver M; Franz L; Heilbron N; Herold B; Horrigan J; Howard J; Kosinski A; Major S; Murias M; Page K; Prasad VK; Sabatos-DeVito M; Sanfilippo F; Sikich L; Simmons R; Song A; Vermeer S; Waters-Pick B; Troy J; Kurtzberg J
    J Pediatr; 2020 Jul; 222():164-173.e5. PubMed ID: 32444220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Umbilical Cord Blood Infusions in the Management of Autism Spectrum Disorder.
    Adnan M; Motiwala F; Trivedi C; Chaudhari G; Mansuri Z; Jain S
    Prim Care Companion CNS Disord; 2022 Jun; 24(3):. PubMed ID: 35666592
    [No Abstract]   [Full Text] [Related]  

  • 4. White Matter Tract Changes Associated with Clinical Improvement in an Open-Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism.
    Carpenter KLH; Major S; Tallman C; Chen LW; Franz L; Sun J; Kurtzberg J; Song A; Dawson G
    Stem Cells Transl Med; 2019 Feb; 8(2):138-147. PubMed ID: 30620122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial.
    Dawson G; Sun JM; Davlantis KS; Murias M; Franz L; Troy J; Simmons R; Sabatos-DeVito M; Durham R; Kurtzberg J
    Stem Cells Transl Med; 2017 May; 6(5):1332-1339. PubMed ID: 28378499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Observations from a Placebo-Controlled, Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells to Improve Symptoms in Children with Autism.
    Chez M; Lepage C; Parise C; Dang-Chu A; Hankins A; Carroll M
    Stem Cells Transl Med; 2018 Apr; 7(4):333-341. PubMed ID: 29405603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological Biomarkers Predict Clinical Improvement in an Open-Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism.
    Murias M; Major S; Compton S; Buttinger J; Sun JM; Kurtzberg J; Dawson G
    Stem Cells Transl Med; 2018 Nov; 7(11):783-791. PubMed ID: 30070044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism.
    Lv YT; Zhang Y; Liu M; Qiuwaxi JN; Ashwood P; Cho SC; Huan Y; Ge RC; Chen XW; Wang ZJ; Kim BJ; Hu X
    J Transl Med; 2013 Aug; 11():196. PubMed ID: 23978163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined social communication therapy at home and in education for young autistic children in England (PACT-G): a parallel, single-blind, randomised controlled trial.
    Green J; Leadbitter K; Ellis C; Taylor L; Moore HL; Carruthers S; James K; Taylor C; Balabanovska M; Langhorne S; Aldred C; Slonims V; Grahame V; Parr J; Humphrey N; Howlin P; McConachie H; Couteur AL; Charman T; Emsley R; Pickles A
    Lancet Psychiatry; 2022 Apr; 9(4):307-320. PubMed ID: 35305746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.
    King BH; Dukes K; Donnelly CL; Sikich L; McCracken JT; Scahill L; Hollander E; Bregman JD; Anagnostou E; Robinson F; Sullivan L; Hirtz D
    JAMA Pediatr; 2013 Nov; 167(11):1045-52. PubMed ID: 24061784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.
    Melamed IR; Heffron M; Testori A; Lipe K
    Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of the synergistic effects of cord blood cells and erythropoietin combination therapy after additional cord blood infusion in children with cerebral palsy: 1-year open-label extension study of randomized placebo-controlled trial.
    Suh MR; Min K; Cho KH; Kim J; Lim I; Park M; Noh EM; Kim MY
    Stem Cell Res Ther; 2023 Dec; 14(1):362. PubMed ID: 38087394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCT.
    Randell E; Wright M; Milosevic S; Gillespie D; Brookes-Howell L; Busse-Morris M; Hastings R; Maboshe W; Williams-Thomas R; Mills L; Romeo R; Yaziji N; McKigney AM; Ahuja A; Warren G; Glarou E; Delport S; McNamara R
    Health Technol Assess; 2022 Jun; 26(29):1-140. PubMed ID: 35766242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy for Global Development Delay and Intellectual Disability.
    Cha B; Kwak H; Bang JI; Jang SJ; Suh MR; Choi JI; Kim M
    Stem Cells Dev; 2023 Apr; 32(7-8):170-179. PubMed ID: 36734415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-emptive intervention versus treatment as usual for infants showing early behavioural risk signs of autism spectrum disorder: a single-blind, randomised controlled trial.
    Whitehouse AJO; Varcin KJ; Alvares GA; Barbaro J; Bent C; Boutrus M; Chetcuti L; Cooper MN; Clark A; Davidson E; Dimov S; Dissanayake C; Doyle J; Grant M; Iacono T; Maybery M; Pillar S; Renton M; Rowbottam C; Sadka N; Segal L; Slonims V; Taylor C; Wakeling S; Wan MW; Wray J; Green J; Hudry K
    Lancet Child Adolesc Health; 2019 Sep; 3(9):605-615. PubMed ID: 31324597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
    Lightdale JR; Hayer C; Duer A; Lind-White C; Jenkins S; Siegel B; Elliott GR; Heyman MB
    Pediatrics; 2001 Nov; 108(5):E90. PubMed ID: 11694674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder.
    Schmitt LM; Smith EG; Pedapati EV; Horn PS; Will M; Lamy M; Barber L; Trebley J; Meyer K; Heiman M; West KHJ; Hughes P; Ahuja S; Erickson CA
    Sci Rep; 2023 Mar; 13(1):5192. PubMed ID: 36997569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial.
    Jacob S; Veenstra-VanderWeele J; Murphy D; McCracken J; Smith J; Sanders K; Meyenberg C; Wiese T; Deol-Bhullar G; Wandel C; Ashford E; Anagnostou E
    Lancet Psychiatry; 2022 Mar; 9(3):199-210. PubMed ID: 35151410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.